VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 181 filers reported holding VANDA PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 5.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $339,000 | -15.7% | 29,640 | -23.5% | 0.02% | -28.0% |
Q1 2020 | $402,000 | -31.4% | 38,760 | +8.6% | 0.02% | +8.7% |
Q4 2019 | $586,000 | +4.3% | 35,705 | -15.6% | 0.02% | -8.0% |
Q3 2019 | $562,000 | -40.3% | 42,295 | -36.7% | 0.02% | -32.4% |
Q2 2019 | $941,000 | -50.6% | 66,815 | -44.0% | 0.04% | +23.3% |
Q4 2016 | $1,904,000 | -4.8% | 119,380 | -0.7% | 0.03% | +7.1% |
Q3 2016 | $2,000,000 | – | 120,205 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Signpost Capital Advisors, LP | 1,688,952 | $27,327,000 | 10.37% |
Palo Alto Investors LP | 3,240,424 | $52,430,000 | 3.90% |
Parametrica Management Ltd | 12,509 | $202,000 | 1.53% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,740,400 | $28,160,000 | 1.08% |
PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC | 557,100 | $9,014,000 | 1.07% |
Westend Capital Management, LLC | 64,086 | $841,000 | 1.00% |
WALL STREET ASSOCIATES | 702,700 | $11,370,000 | 0.98% |
Baker Brothers Advisors | 4,372,153 | $70,741,000 | 0.87% |
Iguana Healthcare Management, LLC | 100,000 | $1,618,000 | 0.76% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,085,301 | $17,560,000 | 0.71% |